| Ytd | 86.52% | |
| 1y | 213.65% |
| Open | 69.44 | Prev Close | 69.74 | Low | 68.22 | High | 70.25 | Mkt Cap | 13.71B |
| Vol | 2.55M | Avg Vol | 3.08M | EPS | 0.77 | P/E | 90.71 | Forward P/E | 33.01 |
| Beta | 1.87 | Short Ratio | 2.79 | Inst. Own | 101.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 58.47 | 200-d Avg | 42.24 | 1yr Est | 66.31 |
BTSG News
Does BrightSpring Health Services, Inc. (BTSG) have what it takes to be a top stock pick for momentu
BTSG's specialty, infusion and provider services momentum support growth, but IRA pressures and inte
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offerin
If you are looking for stocks that are well positioned to maintain their recent uptrend, BrightSprin
Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and risin
BrightSpring, Dycom, StoneX and Orion stand out as buy-worthy stocks, backed by rising cash flows an
Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade
BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the p
TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises
Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a
BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),
BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight